BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31235541)

  • 1. Microsatellite instability diagnosis using the fully automated Idylla platform: feasibility study of an in-house rapid molecular testing ancillary to immunohistochemistry in pathology laboratories.
    Samaison L; Grall M; Staroz F; Uguen A
    J Clin Pathol; 2019 Dec; 72(12):830-835. PubMed ID: 31235541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of microsatellite instability with Idylla MSI assay in colorectal and endometrial cancer.
    Ukkola I; Nummela P; Pasanen A; Kero M; Lepistö A; Kytölä S; Bützow R; Ristimäki A
    Virchows Arch; 2021 Sep; 479(3):471-479. PubMed ID: 33755781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a Fully Automated Idylla Test System for Microsatellite Instability in Colorectal Cancer.
    Li X; Xu J; Li L; Mu X; Wang Y; Li X
    Clin Colorectal Cancer; 2019 Dec; 18(4):e316-e323. PubMed ID: 31375292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idylla MSI test combined with immunohistochemistry is a valuable and cost effective strategy to search for microsatellite instable tumors of noncolorectal origin.
    Samaison L; Uguen A
    Pathol Int; 2022 Apr; 72(4):234-241. PubMed ID: 35083825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of Immunohistochemical and Molecular Methods in Detecting Microsatellite Instability in Gastric Cancer: A Multicenter Study.
    Sousa Marques D; Gullo I; Mascarenhas-Lemos L; Silva JR; Neto do Nascimento C; Pontes P; Pinho L; Cirnes L; Wen X; Cravo M; Carneiro F
    Pathobiology; 2023; 90(6):389-399. PubMed ID: 37271124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting.
    Malapelle U; Parente P; Pepe F; De Luca C; Pisapia P; Sgariglia R; Nacchio M; Gragnano G; Russo G; Conticelli F; Bellevicine C; Vigliar E; Iaccarino A; Covelli C; Balistreri M; Clemente C; Perrone G; Danza A; Scaramuzzi F; Fassan M; Troncone G; Graziano P
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic values of detecting MSI phenotypes in colorectal carcinoma by immunohistochemical method compared to molecular investigation.
    Trabelsi M; Farah F; Blel A; Jaafoura MH; Kharrat M; Rammeh S
    Tunis Med; 2017 Dec; 95(12):229-236. PubMed ID: 29878286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-center real-world comparison of the fully automated Idylla™ microsatellite instability assay with routine molecular methods and immunohistochemistry on formalin-fixed paraffin-embedded tissue of colorectal cancer.
    Velasco A; Tokat F; Bonde J; Trim N; Bauer E; Meeney A; de Leng W; Chong G; Dalstein V; Kis LL; Lorentzen JA; Tomić S; Thwaites K; Putzová M; Birnbaum A; Qazi R; Primmer V; Dockhorn-Dworniczak B; Hernández-Losa J; Soares FA; Gertler AA; Kalman M; Wong C; Carraro DM; Sousa AC; Reis RM; Fox SB; Fassan M; Brevet M; Merkelbach-Bruse S; Colling R; Soilleux E; Teo RYW; D'Haene N; Nolet S; Ristimäki A; Väisänen T; Chapusot C; Soruri A; Unger T; Wecgowiec J; Biscuola M; Frattini M; Long A; Campregher PV; Matias-Guiu X
    Virchows Arch; 2021 May; 478(5):851-863. PubMed ID: 33170334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Performance of the Idylla MSI Test for a Rapid Assessment of the DNA Microsatellite Status in Human Colorectal Cancer.
    Zwaenepoel K; Holmgaard Duelund J; De Winne K; Maes V; Weyn C; Lambin S; Dendooven R; Broeckx G; Steiniche T; Pauwels P
    J Mol Diagn; 2020 Mar; 22(3):386-395. PubMed ID: 31881332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of microsatellite instability (MSI) in upper tract urothelial carcinoma: comparison of the Bethesda panel and the Idylla MSI assay in a consecutively collected, multi-institutional cohort.
    Kullmann F; Strissel PL; Strick R; Stoehr R; Eckstein M; Bertz S; Wullich B; Sikic D; Wach S; Taubert H; Olbert P; Heers H; Lara MF; Macias ML; Matas-Rico E; Lozano MJ; Prieto D; Hierro I; van Doeveren T; Bieche I; Masliah-Planchon J; Beaurepere R; Boormans JL; Allory Y; Herrera-Imbroda B; Hartmann A; Weyerer V
    J Clin Pathol; 2023 Feb; 76(2):126-132. PubMed ID: 34583948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.
    Hall G; Clarkson A; Shi A; Langford E; Leung H; Eckstein RP; Gill AJ
    Pathology; 2010; 42(5):409-13. PubMed ID: 20632815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of Idylla MSI test in colorectal cancer biopsies.
    Ukkola I; Nummela P; Kero M; Ristimäki A
    Diagn Pathol; 2023 Mar; 18(1):39. PubMed ID: 36978094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
    Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
    Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature.
    Zeinalian M; Emami MH; Salehi R; Naimi A; Kazemi M; Hashemzadeh-Chaleshtori M
    J Gastrointest Cancer; 2015 Jun; 46(2):118-25. PubMed ID: 25722176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
    Lawes DA; Pearson T; Sengupta S; Boulos PB
    Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N_LyST: a simple and rapid screening test for Lynch syndrome.
    Susanti S; Fadhil W; Ebili HO; Asiri A; Nestarenkaite A; Hadjimichael E; Ham-Karim HA; Field J; Stafford K; Matharoo-Ball B; Hassall JC; Sharif A; Oniscu A; Ilyas M
    J Clin Pathol; 2018 Aug; 71(8):713-720. PubMed ID: 29472252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsatellite instability evaluation: which test to use for endometrial cancer?
    Rafaniello-Raviele P; Betella I; Rappa A; Vacirca D; Tolva G; Guerrieri-Gonzaga A; Bertario L; Barberis M; Bonanni B; Marabelli M
    J Clin Pathol; 2023 Jan; 76(1):29-33. PubMed ID: 34312297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of 3 molecular-based assays for microsatellite instability detection in formalin-fixed tissues of patients with endometrial and colorectal cancers.
    Gilson P; Levy J; Rouyer M; Demange J; Husson M; Bonnet C; Salleron J; Leroux A; Merlin JL; Harlé A
    Sci Rep; 2020 Oct; 10(1):16386. PubMed ID: 33009475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular Pathology of Colorectal Cancer, Microsatellite Instability - the Detection, the Relationship to the Pathophysiology and Prognosis].
    Brychtová V; Šefr R; Hrstka R; Vídeňská P; Bencsiková B; Hanáková B; Zdražilová Dubská L; Nenutil R; Budinská E
    Klin Onkol; 2017; 30(Supplementum1):153-155. PubMed ID: 28471193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite analysis of sporadic and hereditary gynaecological cancer in routine diagnostics.
    Libera L; Sahnane N; Carnevali IW; Cimetti L; Cerutti R; Chiaravalli AM; Riva C; Tibiletti MG; Sessa F; Furlan D
    J Clin Pathol; 2017 Sep; 70(9):792-797. PubMed ID: 28416640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.